Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies - Ho, P R; Koendgen, H; Campbell, N; Haddock, B; Richman, S; Chang, I (Lancet Neurol, 2017)